Pharma Digest

Jan Majta
  • 0.0 (0)
  • LIFE SCIENCES
  • UPDATED DAILY

A fast paced, AI-generated podcast on pharma and biotech news.

  1. Episode#39 Apr 1st 2026: Lilly's Centessa Bet

    APR 1

    Episode#39 Apr 1st 2026: Lilly's Centessa Bet

    Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience playAmbrosia scores $100M series B to take next-gen oral GLP-1 into the clinicMerck enlists antibody hunter Infinimmune for $838M biobucks pact

    14 min
  2. Episode#38 Mar 31st 2026: Basecamp's Trillion-Gene Atlas

    MAR 31

    Episode#38 Mar 31st 2026: Basecamp's Trillion-Gene Atlas

    Mapping the Trillion-Gene Universe: The Startup That Wants to Teach AI the Language of LifeWhy Data Infrastructure Determines AI Success in Drug DiscoveryPhenoTips, Health Institutions Launch C$5.4M AI Genomic Medicine Initiative in Canada

    14 min
  3. Episode#37 Mar 30th 2026: AstraZeneca's IL‑33 Win

    MAR 30

    Episode#37 Mar 30th 2026: AstraZeneca's IL‑33 Win

    AstraZeneca delivers dream result as phase 3 COPD hits breathe life into class rocked by flops Lilly further embraces Insilico’s AI tech, inking R&D collab worth up to $2.75B Merck dives into detailed phase 3 data showing PCSK9 pill easily outswims rivals

    11 min
  4. Episode#36 March 27th 2026: Merck's $20M Quotient Bet

    MAR 27

    Episode#36 March 27th 2026: Merck's $20M Quotient Bet

    The Value of Prediction, and Cost of Success, in Drug HuntingMerck hands over $20M in IBD drug target deal with Flagship's QuotientThe N-of-1 Revolution in Personalized Medicine

    15 min
  5. Episode#35 Mar 26th 2026: Merck's Terns Play

    MAR 26

    Episode#35 Mar 26th 2026: Merck's Terns Play

    - Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition - OrbiMed-backed Pinnacle adds $89M series B to power oral peptide pipeline - Sarepta's big bet on Arrowhead's siRNA assets yields early data

    12 min
  6. Episode#34 Mar 20th 2026: Baylor Taps Nautilus Voyager

    MAR 20

    Episode#34 Mar 20th 2026: Baylor Taps Nautilus Voyager

    Baylor College of Medicine Taps Nautilus’ Voyager for Cancer ProteomicsThe Download: OpenAI is building a fully automated researcher, and a psychedelic trial blind spotFrom scientist to bioinformatician: how AI coding tools dissolved the activation energy barrier

    14 min
  7. Episode#33 Mar 19th 2026: Lilly's triple‑G diabetes readout

    MAR 19

    Episode#33 Mar 19th 2026: Lilly's triple‑G diabetes readout

    Lilly's triple-G bet lowers blood sugar, prompts 16.8% weight loss in phase 3 diabetes trialSTAT+: A biotech turns to Apple Watch to study its Parkinson’s drugWhich FDA Division Has the Most Stability As AI Tools Get Adopted Across the Agency?

    13 min
  8. Episode#32 Mar 18th 2026: Pharma Digest: Xaira's X‑Atlas

    MAR 18

    Episode#32 Mar 18th 2026: Pharma Digest: Xaira's X‑Atlas

    With its first AI mod­el re­lease, Xaira tests scal­ing laws in vir­tu­al cellsNVIDIA GTC 2026: Agentic AI Inflection Hits Healthcare and Life SciencesDOE Announces $293M Funding Opportunity as Genesis Mission Moves Toward Operational Phase

    13 min
See All (39)

About

A fast paced, AI-generated podcast on pharma and biotech news.

Information

  • Creator
    Jan Majta
  • Years Active
    2K
  • Episodes
    39
  • Rating
    Clean
  • Copyright
    © Jan Majta
  • Show Website
    Pharma Digest